Juergen Wolf, MD | Authors

Articles

Phase II Results of the GEOMETRY Mono-1 Study in NSCLC

October 21, 2018

Juergen Wolf, MD, medical director, Center for Integrated Oncology (CIO) at the University Hospital Cologne, discusses the phase II findings of the GEOMETRY mono-1 study in patients with MET exon 14-mutated advanced non-small cell lung cancer.